Delivery Order SPE2DB22D3301-SPE2DB24FZ1BF

Award Date 7/19/24
Potential Completion Date 7/22/24
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $2,175.99 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Lidocaine 5% patches. The contract has an ultimate completion date of October 17, 2024 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of Lidocaine 5% Patches. The contract has a ceiling value of $1,287.86 and a completion date of May 29, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division, valued at $11,370.41, for the supply of 5% lidocaine patches. The contract has an ultimate completion date of September 30, 2024 and is not set-aside. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of medical commodities, including prescription drugs, vaccines, and medical supplies, to...
The Defense Logistics Agency (DLA) awarded a $2,114.16 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Lidocaine 5% Patches. This contract has no set-aside designation and an ultimate completion date of September 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical through December 2025 for delivering a comprehensive range...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $6,086.15 delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract, which has a completion date of September 11, 2024, is for the supply of Lidocaine 5% patches. This delivery order falls under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Lidocaine 5% Patches. The $2,469.18 firm fixed-price contract has a completion date of May 12, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lidocaine 5% patches. The firm-fixed-price contract has a ceiling value of $6,305.30 and a period of performance through January 31, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lidocaine 5% Patches. The $5,087.75 fixed-price contract has an ultimate completion date of August 28, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,217.63, is for the procurement of Lidocaine 5% patches. The contract has an ultimate completion date of June 13, 2024. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,894.63 firm fixed-price delivery order covers the supply of Lidocaine 5% Patches, which are used for pain management. The contract has an ultimate completion date of November 7, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ1BF
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Lidocaine 5% Patches to support federal healthcare programs. The $2,732.06 contract has an ultimate completion date of July 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a broad range of medical commodities to military treatment facilities worldwide. The company also has a $750,000 IDC with the Department of Justice Federal Bureau of Investigation for pharmaceutical and medical supplies. This award is not set aside and is part of AmerisourceBergen's extensive federal contracting activities to provide critical care medications and medical products to various defense and civilian agencies.

Generated 10/18/24, 9:11 AM